Original Article

Poractant alfa versus beractant for respiratory distress syndrome in preterm infants: A retrospective cohort study

Saritha Paul

Department of Neonatology, King Edward Memorial Hospital for Women, Western Australia, Australia

Department of Neonatology, Princess Margaret Hospital for Children, Perth, Western Australia, Australia

Centre for Neonatal Research and Education, School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia, Australia

Search for more papers by this author

Shripada Rao,

Corresponding Author

Shripada Rao

Department of Neonatology, King Edward Memorial Hospital for Women, Western Australia, Australia

Department of Neonatology, Princess Margaret Hospital for Children, Perth, Western Australia, Australia

Centre for Neonatal Research and Education, School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia, Australia

Correspondence: Dr Shripada Rao, Department of Neonatology, Princess Margaret Hospital for Children, Perth, WA 6008, Australia. Fax: +61 89340 7852; email: [email protected]Search for more papers by this author

Rolland Kohan,

Rolland Kohan

Department of Neonatology, King Edward Memorial Hospital for Women, Western Australia, Australia

Centre for Neonatal Research and Education, School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia, Australia

Search for more papers by this author

Judy McMichael,

Judy McMichael

Department of Neonatology, King Edward Memorial Hospital for Women, Western Australia, Australia

Department of Neonatology, Princess Margaret Hospital for Children, Perth, Western Australia, Australia

Search for more papers by this author

Noel French,

Noel French

Department of Neonatology, King Edward Memorial Hospital for Women, Western Australia, Australia

Centre for Neonatal Research and Education, School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia, Australia

Search for more papers by this author

Guicheng Zhang,

Guicheng Zhang

Department of Statistics, Princess Margaret Hospital for Children, Perth, Western Australia, Australia

Search for more papers by this author

Karen Simmer,

Karen Simmer

Department of Neonatology, King Edward Memorial Hospital for Women, Western Australia, Australia

Department of Neonatology, Princess Margaret Hospital for Children, Perth, Western Australia, Australia

Centre for Neonatal Research and Education, School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia, Australia

Search for more papers by this author

Saritha Paul,

Saritha Paul

Department of Neonatology, King Edward Memorial Hospital for Women, Western Australia, Australia

Department of Neonatology, Princess Margaret Hospital for Children, Perth, Western Australia, Australia

Centre for Neonatal Research and Education, School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia, Australia

Search for more papers by this author

Shripada Rao,

Corresponding Author

Shripada Rao

Department of Neonatology, King Edward Memorial Hospital for Women, Western Australia, Australia

Department of Neonatology, Princess Margaret Hospital for Children, Perth, Western Australia, Australia

Centre for Neonatal Research and Education, School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia, Australia

Rolland Kohan,

Rolland Kohan

Department of Neonatology, King Edward Memorial Hospital for Women, Western Australia, Australia

Centre for Neonatal Research and Education, School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia, Australia

Search for more papers by this author

Judy McMichael,

Judy McMichael

Department of Neonatology, King Edward Memorial Hospital for Women, Western Australia, Australia

Department of Neonatology, Princess Margaret Hospital for Children, Perth, Western Australia, Australia

Search for more papers by this author

Noel French,

Noel French

Department of Neonatology, King Edward Memorial Hospital for Women, Western Australia, Australia

Centre for Neonatal Research and Education, School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia, Australia

Search for more papers by this author

Guicheng Zhang,

Guicheng Zhang

Department of Statistics, Princess Margaret Hospital for Children, Perth, Western Australia, Australia

Search for more papers by this author

Karen Simmer,

Karen Simmer

Department of Neonatology, King Edward Memorial Hospital for Women, Western Australia, Australia

Department of Neonatology, Princess Margaret Hospital for Children, Perth, Western Australia, Australia

Centre for Neonatal Research and Education, School of Paediatrics and Child Health, University of Western Australia, Perth, Western Australia, Australia

Search for more papers by this author

First published: 26 June 2013

https://doi.org/10.1111/jpc.12300

Citations: 22

Conflict of interest: None of the authors have any conflict of interest. This study received no funding. None of the investigators have any affiliation to the surfactant manufacturing industry.

Share a link

Email
Wechat
Bluesky

Abstract

Aim

Poractant alfa and beractant are the commonly used animal derived surfactants in preterm infants with respiratory distress syndrome. Between 2005 and 2007, poractant alfa and beractant were alternated every month in our neonatal intensive care unit for 27 months. The aim of this study was to compare the outcomes of preterm infants who received poractant alfa versus beractant.

Method

Single-centre, retrospective cohort study of inborn preterm infants <32 weeks gestation (23–31⁺⁶).

Results

Six hundred sixty-four preterm infants (<32 weeks) were born during the study period, of which 415 received surfactant (poractant alfa: 214; beractant: 201). Infants in the poractant alfa group were 2.8 days younger than beractant (27.0 ± 2.3 vs. 27.4 ± 2.3 weeks; P = 0.03). All other baseline characters including Clinical Risk Index for Babies II scores were similar for both groups. No significant differences were found for the following outcomes: death or chronic lung disease (78/212 vs. 59/200; P = 0.28); death (24/214 vs. 15/201, P = 0.24); moderate to severe chronic lung disease (63/212 vs. 46/200; P = 0.45) and moderate to severe disability (20/163 vs. 19/151, P = 0.98) between poractant alfa and beractant, respectively.

Conclusions

The results of our study do not support the need for preferential use of poractant alfa or beractant.

References

1 Seger N, Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst. Rev. 2009; (2): CD007836.
10.1002/14651858.CD007836
PubMed Web of Science® Google Scholar
2 Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst. Rev. 2001; (2): CD000144.
10.1002/14651858.CD000144
Google Scholar
3 van Kaam AH, De Jaegere AP, Borensztajn D, Rimensberger PC. Surfactant replacement therapy in preterm infants: a European survey. Neonatology 2011; 100: 71–77.
10.1159/000322004
CAS PubMed Web of Science® Google Scholar
4 Halliday HL. History of surfactant from 1980. Biol. Neonate 2005; 87: 317–322.
10.1159/000084879
CAS PubMed Google Scholar
5 Parry G, Tucker J, Tarnow-Mordi W. CRIB II: an update of the clinical risk index for babies score. Lancet 2003; 361: 1789–1791.
10.1016/S0140-6736(03)13397-1
PubMed Web of Science® Google Scholar
6 Ehrenkranz RA, Walsh MC, Vohr BR et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116: 1353–1360.
10.1542/peds.2005-0249
PubMed Web of Science® Google Scholar
7 Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 2001; 163: 1723–1729.
10.1164/ajrccm.163.7.2011060
CAS PubMed Google Scholar
8 M Huntley, ed. The Griffiths Mental Development Scales from birth to 2 years manual. 1996 revision: association for research in Infant and Child Development. 1996.
Google Scholar
9 Bayley N. Bayley Scales of Infant and Toddler Development. San Antonio, TX: The Psychological Corporation, 2006.
Google Scholar
10 Ramanathan R, Bhatia JJ, Sekar K, Ernst FR. Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study. J. Perinatol. 2013; 33: 119–125.
10.1038/jp.2011.125
CAS PubMed Web of Science® Google Scholar
11 Singh N, Hawley KL, Viswanathan K. Efficacy of porcine versus bovine surfactants for preterm newborns with respiratory distress syndrome: systematic review and meta-analysis. Pediatrics 2011; 128: e1588–1595.
10.1542/peds.2011-1395
PubMed Web of Science® Google Scholar
12 Baroutis G, Kaleyias J, Liarou T, Papathoma E, Hatzistamatiou Z, Costalos C. Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Eur. J. Pediatr. 2003; 162: 476–480.
10.1007/s00431-002-1144-0
CAS PubMed Web of Science® Google Scholar
13 Fujii AM, Patel SM, Allen R, Doros G, Guo CY, Testa S. Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome. J. Perinatol. 2010; 30: 665–670.
10.1038/jp.2010.20
CAS PubMed Web of Science® Google Scholar
14 Gharehbaghi MM, Sakha SH, Ghojazadeh M, Firoozi F. Complications among premature neonates treated with beractant and poractant alfa. Indian J. Pediatr. 2010; 77: 751–754.
10.1007/s12098-010-0097-y
PubMed Web of Science® Google Scholar
15 Malloy CA, Nicoski P, Muraskas JK. A randomized trial comparing beractant and poractant alfa treatment in neonatal respiratory distress syndrome. Acta Paediatr. 2005; 94: 779–784.
10.1080/08035250510028740
PubMed Web of Science® Google Scholar
16 Ramanathan R, Rasmussen MR, Gerstmann DR, Finer N, Sekar K. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am. J. Perinatol. 2004; 21: 109–119.
10.1055/s-2004-823779
PubMed Web of Science® Google Scholar
17 Speer CP, Gefeller O, Groneck P et al. Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Arch. Dis. Child. Fetal Neonatal Ed. 1995; 72: F8–13.
10.1136/fn.72.1.F8
CAS PubMed Web of Science® Google Scholar
18 Dizdar EA, Sari FN, Aydemir C et al. A randomized, controlled trial of poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome. Am. J. Perinatol. 2012; 29: 95–100.
10.1055/s-0031-1295648
PubMed Web of Science® Google Scholar
19 Borzak S, Ridker PM. Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction. Ann. Intern. Med. 1995; 123: 873–877.
10.7326/0003-4819-123-11-199512010-00010
CAS PubMed Web of Science® Google Scholar
20 Flather MD, Farkouh ME, Pogue JM, Yusuf S. Strengths and limitations of meta-analysis: larger studies may be more reliable. Control. Clin. Trials 1997; 18: 568–579. discussion 661-566.
10.1016/S0197-2456(97)00024-X
CAS PubMed Web of Science® Google Scholar
21 Hennekens CH, Demets D. The need for large-scale randomized evidence without undue emphasis on small trials, meta-analyses, or subgroup analyses. JAMA 2009; 302: 2361–2362.
10.1001/jama.2009.1756
CAS PubMed Web of Science® Google Scholar
22 Sweet DG, Carnielli V, Greisen G et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants – 2010 update. Neonatology 2010; 97: 402–417.
10.1159/000297773
PubMed Web of Science® Google Scholar
23 Engle WA. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 2008; 121: 419–432.
10.1542/peds.2007-3283
PubMed Web of Science® Google Scholar
24 Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000; 355: 1064–1069.
10.1016/S0140-6736(00)02039-0
CAS PubMed Web of Science® Google Scholar
25 Fletcher J. Subgroup analyses: how to avoid being misled. BMJ 2007; 335: 96–97.
10.1136/bmj.39265.596262.AD
PubMed Web of Science® Google Scholar

Citing Literature

Volume49, Issue10

October 2013

Pages 839-844

Poractant alfa versus beractant for respiratory distress syndrome in preterm infants: A retrospective cohort study

Abstract

Aim

Method

Results

Conclusions

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Poractant alfa versus beractant for respiratory distress syndrome in preterm infants: A retrospective cohort study

Abstract

Aim

Method

Results

Conclusions

References

Citing Literature

References

Related

Information